These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 11980845

  • 1. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW, Pang CP, To KF, Yu CB, Ng JS, Lam DS.
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [Abstract] [Full Text] [Related]

  • 2. [Abnormal methylation of several tumor suppressor genes in sporadic breast cancer].
    Zemliakova VV, Zhevlova AI, Strel'nikov VV, Liubchenko LN, Vishnevskaia IaV, Tret'iakova VA, Zaletaev DV, Nemtsova MV.
    Mol Biol (Mosk); 2003 May; 37(4):696-703. PubMed ID: 12942643
    [Abstract] [Full Text] [Related]

  • 3. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 4. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K.
    Pathol Int; 2004 Aug 15; 54(8):549-55. PubMed ID: 15260845
    [Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
    Viswanathan M, Tsuchida N, Shanmugam G.
    Int J Cancer; 2003 May 20; 105(1):41-6. PubMed ID: 12672028
    [Abstract] [Full Text] [Related]

  • 6. Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.
    Watanabe T, Katayama Y, Yoshino A, Yachi K, Ohta T, Ogino A, Komine C, Fukushima T.
    Brain Pathol; 2007 Jan 20; 17(1):5-10. PubMed ID: 17493032
    [Abstract] [Full Text] [Related]

  • 7. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H, Miyazaki K.
    Ann Surg Oncol; 2005 May 20; 12(5):354-63. PubMed ID: 15915369
    [Abstract] [Full Text] [Related]

  • 8. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T.
    J Neuropathol Exp Neurol; 2005 May 20; 64(5):398-403. PubMed ID: 15892297
    [Abstract] [Full Text] [Related]

  • 9. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC.
    Carcinogenesis; 2004 May 20; 25(5):661-8. PubMed ID: 14688019
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
    Zhang YJ, Chen Y, Ahsan H, Lunn RM, Lee PH, Chen CJ, Santella RM.
    Int J Cancer; 2003 Feb 10; 103(4):440-4. PubMed ID: 12478658
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y.
    Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.
    Choy KW, Lee TC, Cheung KF, Fan DS, Lo KW, Beaverson KL, Abramson DH, Lam DS, Yu CB, Pang CP.
    Neoplasia; 2005 Mar 01; 7(3):200-6. PubMed ID: 15799820
    [Abstract] [Full Text] [Related]

  • 13. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI, Lee HS, Kim SH, Kim WH.
    Br J Cancer; 2002 Jun 17; 86(12):1888-92. PubMed ID: 12085181
    [Abstract] [Full Text] [Related]

  • 15. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 16. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.
    Lin Z, Gao M, Zhang X, Kim YS, Lee ES, Kim HK, Kim I.
    J Cancer Res Clin Oncol; 2005 Jun 01; 131(6):364-70. PubMed ID: 15785933
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP.
    Clin Cancer Res; 2002 Jan 01; 8(1):131-7. PubMed ID: 11801549
    [Abstract] [Full Text] [Related]

  • 19. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 01; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer.
    Yeh KT, Chang JG, Lin TH, Wang YF, Tien N, Chang JY, Chen JC, Shih MC.
    Oncol Rep; 2003 Sep 01; 10(3):659-63. PubMed ID: 12684640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.